Q24-14782-31625
4 vaccinations
3 coded responses
47 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 786 / TX
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
5QC-13613-27091
Child or adolescent in my care · Female · 2022-06-26
Timeline
-
2021-04-01
Dose 1 — Moderna
-
2021-04-09
Registered in v-safe
- 2021-04-09
- 2021-04-15
- 2021-04-22
-
2021-04-29
Dose 2 — Moderna
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-05-02
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-05-05
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-07-29
-
2021-10-28
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: Very minor coldMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Dose 3 — Moderna
- 2021-11-27
-
2021-11-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-01-01
- 2022-01-08
-
2022-02-26
Survey response — 3 months, dose 3MedDRA: Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, runny nose, feverMedDRA releases: 2024-11 · check-in free text available
-
2022-05-28
Survey response — 6 months, dose 3MedDRA: Alopecia — Feeling: GoodFree text: Hair lossMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Dose 4 — Moderna
-
2022-11-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-11-02
- 2022-11-03
- 2022-11-04
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2022-11-28
- 2022-12-05
- 2022-12-12
- 2023-02-01
- 2023-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Moderna | |
| 2 | 2021-04-29 | Moderna | |
| 3 | 2021-11-27 | Moderna | No |
| 4 | 2022-10-31 | Moderna | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Very minor cold
Release 11 — 3 months, dose 3
Symptoms: Sore throat, runny nose, fever
Release 11 — 6 months, dose 3
Symptoms: Hair loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alopecia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release